Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmaceutical prescriptions in Italy

S Garattini1

  • 1Instituto de Richerche Farmacologiche Mario Negri.

International Journal of Technology Assessment in Health Care
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat.

Naunyn-Schmiedeberg's archives of pharmacology·1996
Same author

Pharmacology of ingestive behaviour.

Therapie·1996
Same author

DNA topoisomerase inhibitors.

Cancer chemotherapy and biological response modifiers·1996
Same author

Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse. A comparison with the rat.

Neuropharmacology·1995
Same author

Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primates.

Xenobiotica; the fate of foreign compounds in biological systems·1995
Same author

Biological actions of drugs affecting serotonin and eating.

Obesity research·1995

Pharmaceutical prescriptions varied significantly across four European nations. Italy

Area of Science:

  • Pharmacoeconomics
  • Health Policy Analysis
  • Pharmaceutical Market Research

Background:

  • Significant divergence exists in pharmaceutical prescribing patterns across major European countries.
  • In 1992, only seven active pharmaceutical ingredients were common among the top 50 products by value in Italy, France, Germany, and the UK.
  • This highlights substantial national differences in drug utilization and market composition.

Purpose of the Study:

  • To analyze the impact of a new National Health System (NHS) reimbursement policy in Italy based on drug efficacy.
  • To investigate the subsequent changes in the Italian pharmaceutical market following the policy implementation.
  • To discuss the pharmacologic and economic implications of this policy shift.

Main Methods:

  • Comparative analysis of pharmaceutical sales data by value in four European countries (Italy, France, Germany, UK) for 1992.

Related Experiment Videos

  • Analysis of the top 50 most-sold pharmaceutical products by value in Italy before and after the policy change in 1994.
  • Qualitative discussion of pharmacologic and economic consequences.

    • Main Results:

    • In 1992, a low overlap (seven active principles) was observed in the top 50 products by value across the four studied European countries.
    • Following Italy's 1994 policy shift to efficacy-based reimbursement by the NHS, the list of top 50 products by value underwent dramatic changes within the first five months.
    • The new policy significantly altered pharmaceutical market dynamics in Italy.

    Conclusions:

    • National health policies, particularly reimbursement strategies based on efficacy, profoundly influence pharmaceutical market composition and drug prescribing.
    • The Italian case demonstrates a rapid and substantial shift in the pharmaceutical landscape due to policy reform.
    • Understanding these pharmacoeconomic dynamics is crucial for healthcare systems and pharmaceutical manufacturers.